SFRS3 (9C11) Monoclonal Antibody

$Lane 1: Mouse testis; Lane 2: Rat brain; Lane 3: A431 Cells; Lane 4: SH-SY-5Y Cells; Lane 5: SiHa Cells; Lane 6: 293 Cells; Lane 7: Hela Cells; Lane 8: HepG2 Cells; Lane 9: A549 Cells; Probed with SFRS3 (9C11) Monoclonal Antibody (bsm-54467R) at 1:500, overnight at 4\u00b0C followed by a conjugated secondary antibody for 60 minutes at 37\u00b0C.$

Lane 1: Mouse testis; Lane 2: Rat brain; Lane 3: A431 Cells; Lane 4: SH-SY-5Y Cells; Lane 5: SiHa Cells; Lane 6: 293 Cells; Lane 7: Hela Cells; Lane 8: HepG2 Cells; Lane 9: A549 Cells; Probed with SFRS3 (9C11) Monoclonal Antibody (bsm-54467R) at 1:500, overnight at 4\u00b0C followed by a conjugated secondary antibody for 60 minutes at 37\u00b0C.

$Paraformaldehyde-fixed and paraffin-embedded Rat Brain tissue incubated with SFRS3 (9C11) Monoclonal Antibody (bsm-54467R) at 1:200, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin. The tissue was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes.$

Paraformaldehyde-fixed and paraffin-embedded Rat Brain tissue incubated with SFRS3 (9C11) Monoclonal Antibody (bsm-54467R) at 1:200, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin. The tissue was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes.

$Paraformaldehyde-fixed and paraffin-embedded Human Colon tissue incubated with SFRS3 (9C11) Monoclonal Antibody (bsm-54467R) at 1:200, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin. The tissue was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes.$

Paraformaldehyde-fixed and paraffin-embedded Human Colon tissue incubated with SFRS3 (9C11) Monoclonal Antibody (bsm-54467R) at 1:200, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin. The tissue was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes.

$Paraformaldehyde-fixed and paraffin-embedded Human Breast Cancer tissue incubated with SFRS3 (9C11) Monoclonal Antibody (bsm-54467R) at 1:200, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin. The tissue was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes.$

Paraformaldehyde-fixed and paraffin-embedded Human Breast Cancer tissue incubated with SFRS3 (9C11) Monoclonal Antibody (bsm-54467R) at 1:200, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin. The tissue was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes.

$Paraformaldehyde-fixed and paraffin-embedded Human Kidney tissue incubated with SFRS3 (9C11) Monoclonal Antibody (bsm-54467R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin. The tissue was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes.$

Paraformaldehyde-fixed and paraffin-embedded Human Kidney tissue incubated with SFRS3 (9C11) Monoclonal Antibody (bsm-54467R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin. The tissue was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes.

$Paraformaldehyde-fixed and paraffin-embedded Mouse Testis tissue incubated with SFRS3 (9C11) Monoclonal Antibody (bsm-54467R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin. The tissue was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes.$

Paraformaldehyde-fixed and paraffin-embedded Mouse Testis tissue incubated with SFRS3 (9C11) Monoclonal Antibody (bsm-54467R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin. The tissue was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes.

Applications

WB
IHC-P
IF(ICC)

Reactivity

Human
Mouse
Rat

Overview
Catalog #	bsm-54468R
Product Name	SFRS3 (9C11) Monoclonal Antibody
Applications	WB IHC-P IF(ICC)
Reactivity	Human, Mouse, Rat
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	Full length recombinant protein.
Clonality	Monoclonal
Clone #	9C11
Isotype	IgG
Concentration	1ug/ul
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition	Store at -20C for 12 months.
Target
Gene ID	6428
Swiss Prot	P84103
Subcellular location	Cytoplasm, Nucleus
Synonyms	Serine/arginine-rich splicing factor 3; SRSF3; Pre-mRNA-splicing factor SRP20; Splicing factor arginine/serine-rich 3; SRP20
Background	Splicing factor that specifically promotes exon-inclusion during alternative splicing. Interaction with YTHDC1, a RNA-binding protein that recognizes and binds N6-methyladenosine (m6A)-containing RNAs, promotes recruitment of SRSF3 to its mRNA-binding elements adjacent to m6A sites, leading to exon-inclusion during alternative splicing. Also functions as export adapter involved in mRNA nuclear export. Binds mRNA which is thought to be transferred to the NXF1-NXT1 heterodimer for export (TAP/NXF1 pathway); enhances NXF1-NXT1 RNA-binding activity. Involved in nuclear export of m6A-containing mRNAs via interaction with YTHDC1: interaction with YTHDC1 facilitates m6A-containing mRNA-binding to both SRSF3 and NXF1, promoting mRNA nuclear export. RNA-binding is semi-sequence specific
Application Dilution
WB	1:300-5000
IHC-P	1:200-400
IF(ICC)	1:50-200